rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gary M. Pfeiffer

Director

Company insider

Files Form 4 as: Director, Quest Diagnostics; Director, Internap; Director, TerraVia Holdings; Director, Talbots; Senior Vice President & CFO, Dupont E I De Nemours & Co.

In numbers

Trades disclosed
145
Buys
1
Sells
9
Bought
$66K
Sold
$7.2M
Companies
5
Companies where not an officer
4
First trade
1 Jan 2006
Last trade
26 Oct 2026
Last filed
28 Oct 2026

Companies traded

Where they are an officer
Dupont E I De Nemours & CoOfficer · last 12 Jun 20060 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
DGX Quest DiagnosticsDirector · Diagnostics & Labs · last 26 Oct 20260 buys · 9 sells
InternapDirector · last 8 May 20201 buy · 0 sells
TerraVia HoldingsDirector · last 22 May 20170 buys · 0 sells
TalbotsDirector · last 3 Aug 20120 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Oct 2026filed 28 Oct 2026DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Sold$292K1,203 at $243.00filing
20 May 2026filed 21 May 2026DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,142 at $0.00filing
20 May 2026filed 21 May 2026DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,142 at $0.00filing
23 Oct 2025filed 24 Oct 2025DGX Quest Diagnosticsoption or derivative · Diagnostics & LabsSEC FORM 4 Code I$841K4,413.28 at $190.58filing
22 Oct 2025filed 24 Oct 2025DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Sold$270K1,482 at $182.40filing
15 May 2025filed 19 May 2025DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,203 at $0.00filing
16 May 2024filed 20 May 2024DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,482 at $0.00filing
17 May 2023filed 19 May 2023DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,369 at $0.00filing
18 May 2022filed 20 May 2022DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,292 at $0.00filing
25 May 2021filed 25 May 2021DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,363 at $0.00filing
19 May 2020filed 21 May 2020DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,531 at $0.00filing
8 May 2020filed 8 May 2020Internapoption or derivativeSEC FORM 4 Code J—4,072 at $0.00filing
8 May 2020filed 8 May 2020InternapSEC FORM 4 Code J—80,695 at $0.00filing
6 Jun 2019filed 10 Jun 2019InternapSEC FORM 4 Code A—26,726 at $0.00filing
14 May 2019filed 16 May 2019DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,722 at $0.00filing
12 Nov 2018filed 14 Nov 2018InternapSEC FORM 4 Bought$66K10,000 at $6.56filing
30 Sep 2018filed 2 Oct 2018InternapSEC FORM 4 Code A—1,819 at $0.00filing
30 Jun 2018filed 3 Jul 2018InternapSEC FORM 4 Code A—1,316 at $0.00filing
7 Jun 2018filed 11 Jun 2018InternapSEC FORM 4 Code A—9,557 at $0.00filing
15 May 2018filed 17 May 2018DGX Quest DiagnosticsDiagnostics & LabsSEC FORM 4 Code A—1,644 at $0.00filing

Sectors

Health Care9
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

J. E. DavisCEO and President · Also traded DGX in the last 90 days
Michael E. PrevoznikSVP & General Counsel · Also traded DGX in the last 90 days